Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

Overview of attention for article published in BMC Cancer, October 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 14,048 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.